# Evaluation of the Clinical Effectiveness and Safety of Acellular Dermal Matrix(SC DERM® Recon) in Breast Reconstruction

> **NCT06555692** · — · ACTIVE_NOT_RECRUITING · sponsor: **DOF Inc.** · enrollment: 120 (estimated)

## Conditions studied

- Breast Cancer Female
- Breast Reconstruction

## Interventions

- **BIOLOGICAL:** Transplant acellular dermal matrix(ADM)

## Key facts

- **NCT ID:** NCT06555692
- **Lead sponsor:** DOF Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-01-04
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06555692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06555692, "Evaluation of the Clinical Effectiveness and Safety of Acellular Dermal Matrix(SC DERM® Recon) in Breast Reconstruction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06555692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*